We are very grateful to Dr George Follows for making the slides used at a presentation he gave to the UK CLL Forum on real-world use of ibrutinib on the 5th of October 2016. As you may know, this was a big project that he was keen to complete before he handed over the Chairmanship of the UK CLL Forum to his colleague from Oxford, Anna Schuh. This evaluation has now been accepted for publication and should be easy to find in the journal ‘haematologica’ when it goes on line.
Read Dr Follows covering note to the slides which are attached as a power point to the note.
cllsupport.org.uk/article/r...
A link to the paper on haematologica will be posted as soon as it is published.
Follow up to static dilemma 
ibrutinib, opposite effect.
Ibrutinib as a monotherapy
New gold standard for first line treatment UK?
